Westpac Banking Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Westpac Banking Corp’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,941	Closed	-$1.96M	–	804
2023 Q1	$1.96M	Hold	17,941	–	–	0.03%	526
2022 Q4	$2.04M	Hold	17,941	–	–	0.03%	508
2022 Q3	$1.11M	Hold	17,941	–	–	0.02%	601
2022 Q2	$1.43M	Hold	17,941	–	–	0.02%	602
2022 Q1	$1.89M	Hold	17,941	–	–	0.02%	586
2021 Q4	$1.93M	Hold	17,941	–	–	0.02%	575
2021 Q3	$1.97M	Hold	17,941	–	–	0.02%	592
2021 Q2	$1.68M	Buy	+17,941	New	+$1.65M	0.02%	645
2021 Q1	–	Sell	-17,941	Closed	-$1.31M	–	866
2020 Q4	$1.31M	Buy	+17,941	New	+$1.33M	0.01%	656

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Westpac Banking Corp's HZNP Position: Q2 2023 in Review

Westpac Banking Corp sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 17,941 shares — an estimated $1.96M sold.

Westpac Banking Corp first reported a position in HZNP in Q4 2020 and held it in 9 quarters. The position peaked at $2.04M in Q4 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Westpac Banking Corp reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Westpac Banking Corp sold 17,941 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $1.96M.
Westpac Banking Corp first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 9 quarters.
Westpac Banking Corp's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.04M in Q4 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Westpac Banking Corp's 13F filing for Q2 2023, filed 10 Aug 2023.